Testimony
Adjustment to DEA Aggregate Production Quota in Support of Coronavirus Pandemic
April 07, 2020
|
| Download Document
The Drug Enforcement Administration is adjusting the 2020 aggregate production quotas for certain controlled substances in schedule II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine and pseudoephedrine. This increase is in response to the current nationwide COVID-19 public health emergency as declared by the Secretary of Health and Human Services on January 31, 2020.
Attachments
DEA508A -Adjustment2020APQ FINAL signed 4-6-20.pdf